The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes
Open accessAbstract
Type 1 diabetes (T1D) results from destruction of pancreatic beta cells by T cells of the immune system. Despite improvements in insulin analogs and continuous blood glucose level monitoring, there is no cure for T1D, and some individuals develop life-threatening complications. Pancreas and islet transplantation have been attractive therapeutic approaches; however, transplants containing insulin-producing cells are vulnerable to both recurrent autoimmunity and conventional allograft rejection. Current immune suppression treatments subdue the immune system, but not without complications. Ideally a successful approach would target only the destructive immune cells and leave the remaining immune system intact to fight foreign pathogens. This review discusses the autoimmune diabetes disease process, diabetic complications that warrant a transplant, and alloimmunity. First, we describe the current understanding of autoimmune destruction of beta cells including the roles of CD4 and CD8 T cells and several possibilities for antigen-specific tolerance induction. Second, we outline diabetic complications necessitating beta cell replacement. Third, we discuss transplant recognition, potential sources for beta cell replacement, and tolerance-promoting therapies under development. We hypothesize that a better understanding of autoreactive T cell targets during disease pathogenesis and alloimmunity following transplant destruction could enhance attempts to re-establish tolerance to beta cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Generation of Functional Human Pancreatic β Cells In Vitro
Pagliuca, F. W., Millman, J. R., Gürtler, M., Segel, M., Van Dervort, A., Ryu, J. H., Peterson, Q. P., Greiner, D., & Melton, D. A. (2014) · Cell · doi:10.1016/j.cell.2014.09.040 · Cited by 2,025
Eisenbarth (1986) · doi:10.1056/nejm198605223142106 · Cited by 1,659
Five-Year Follow-Up After Clinical Islet Transplantation
Ryan, E. A., Paty, B. W., Senior, P. A., Bigam, D., Alfadhli, E., Kneteman, N. M., Lakey, J. R. T., & Shapiro, A. M. J. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2060 · Cited by 1,641
Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells
Rezania, A., Bruin, J. E., Arora, P., Rubin, A., Batushansky, I., Asadi, A., O'Dwyer, S., Quiskamp, N., Mojibian, M., Albrecht, T., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.3033 · Cited by 1,575
Breeding of a Non-Obese, Diabetic Strain of Mice
MAKINO, S., KUNIMOTO, K., MURAOKA, Y., MIZUSHIMA, Y., KATAGIRI, K., & TOCHINO, Y. (1980) · Experimental Animals · doi:10.1538/expanim1978.29.1_1 · Cited by 1,249
THE NOD MOUSE: A Model of Immune Dysregulation
Anderson, M. S., & Bluestone, J. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115643 · Cited by 1,113
Kaufman, D. L., Clare-Salzler, M., Tian, J., Forsthuber, T., Ting, G. S. P., Robinson, P., Atkinson, M. A., Sercarz, E. E., Tobin, A. J., & Lehmann, P. V. (1993) · Nature · doi:10.1038/366069a0 · Cited by 1,070
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Bluestone, J. A., Buckner, J. H., Fitch, M., Gitelman, S. E., Gupta, S., Hellerstein, M. K., Herold, K. C., Lares, A., Lee, M. R., Li, K., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad4134 · Cited by 1,033
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705894104 · Cited by 1,014
Pugliese, A., Zeller, M., Fernandez, A., Zalcberg, L. J., Bartlett, R. J., Ricordi, C., Pietropaolo, M., Eisenbarth, G. S., Bennett, S. T., & Patel, D. D. (1997) · Nature Genetics · doi:10.1038/ng0397-293 · Cited by 945
Clinical Outcomes and Insulin Secretion After Islet Transplantation With the Edmonton Protocol
Ryan, E. A., Lakey, J. R. T., Rajotte, R. V., Korbutt, G. S., Kin, T., Imes, S., Rabinovitch, A., Elliott, J. F., Bigam, D., Kneteman, N. M., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.4.710 · Cited by 864
Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice
Nakayama, M., Abiru, N., Moriyama, H., Babaya, N., Liu, E., Miao, D., Yu, L., Wegmann, D. R., Hutton, J. C., Elliott, J. F., et al. (2005) · Nature · doi:10.1038/nature03523 · Cited by 758
Clinical pancreatic islet transplantation
Shapiro, A. M. J., Pokrywczynska, M., & Ricordi, C. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.178 · Cited by 747
Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction
Tang, Q., Adams, J. Y., Penaranda, C., Melli, K., Piaggio, E., Sgouroudis, E., Piccirillo, C. A., Salomon, B. L., & Bluestone, J. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.016 · Cited by 729
Diabetic cardiomyopathy, causes and effects
Boudina, S., & Abel, E. D. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9131-7 · Cited by 728
Following a diabetogenic T cell from genesis through pathogenesis
Katz, J. D., Wang, B., Haskins, K., Benoist, C., & Mathis, D. (1993) · Cell · doi:10.1016/0092-8674(93)90730-e · Cited by 696
Coppieters, K. T., Dotta, F., Amirian, N., Campbell, P. D., Kay, T. W. H., Atkinson, M. A., Roep, B. O., & von Herrath, M. G. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111187 · Cited by 672
T Helper Cell Subsets in Insulin-Dependent Diabetes
Katz, J. D., Benoist, C., & Mathis, D. (1995) · Science · doi:10.1126/science.7761837 · Cited by 593
Genetic risk factors for type 1 diabetes
Pociot, F., & Lernmark, Å. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30582-7 · Cited by 553
Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion
Delong, T., Wiles, T. A., Baker, R. L., Bradley, B., Barbour, G., Reisdorph, R., Armstrong, M., Powell, R. L., Reisdorph, N., Kumar, N., et al. (2016) · Science · doi:10.1126/science.aad2791 · Cited by 503
Keenan, H. A., Sun, J. K., Levine, J., Doria, A., Aiello, L. P., Eisenbarth, G., Bonner-Weir, S., & King, G. L. (2010) · Diabetes · doi:10.2337/db10-0676 · Cited by 500
Arif, S., Tree, T. I., Astill, T. P., Tremble, J. M., Bishop, A. J., Dayan, C. M., Roep, B. O., & Peakman, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19585 · Cited by 479
Serreze, D. V., Fleming, S. A., Chapman, H. D., Richard, S. D., Leiter, E. H., & Tisch, R. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.3912 · Cited by 456
Yu, L., Robles, D. T., Abiru, N., Kaur, P., Rewers, M., Kelemen, K., & Eisenbarth, G. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040556697 · Cited by 450
Grinberg-Bleyer, Y., Baeyens, A., You, S., Elhage, R., Fourcade, G., Gregoire, S., Cagnard, N., Carpentier, W., Tang, Q., Bluestone, J., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100209 · Cited by 433
Marek-Trzonkowska, N., Myśliwiec, M., Dobyszuk, A., Grabowska, M., Techmańska, I., Juścińska, J., Wujtewicz, M. A., Witkowski, P., Młynarski, W., Balcerska, A., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0038 · Cited by 431
Wong, F. S., Karttunen, J., Dumont, C., Wen, L., Visintin, I., Pilip, I. M., Shastri, N., Pamer, E. G., & Janeway, C. A. (1999) · Nature Medicine · doi:10.1038/12465 · Cited by 430
The Molecular Basis of Allorecognition
Sherman, L. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.385 · Cited by 403
Marek-Trzonkowska, N., Myśliwiec, M., Dobyszuk, A., Grabowska, M., Derkowska, I., Juścińska, J., Owczuk, R., Szadkowska, A., Witkowski, P., Młynarski, W., et al. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.03.016 · Cited by 384 · cited 1×
“A European group isolated and expanded Tregs from T1D patients (130) and then went on to demonstrate preservations of C-peptide in 8 of 12 subjects and reversal of new-onset T1D in 2 patients (131).”
BackgroundExpansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes
Putnam, A. L., Brusko, T. M., Lee, M. R., Liu, W., Szot, G. L., Ghosh, T., Atkinson, M. A., & Bluestone, J. A. (2009) · Diabetes · doi:10.2337/db08-1168 · Cited by 357
Immunotherapy of the Nonobese Diabetic Mouse: Treatment with an Antibody to T-Helper Lymphocytes
Shizuru, J. A., Taylor-Edwards, C., Banks, B. A., Gregory, A. K., & Fathman, C. G. (1988) · Science · doi:10.1126/science.2966437 · Cited by 345
Chromogranin A is an autoantigen in type 1 diabetes
Stadinski, B. D., Delong, T., Reisdorph, N., Reisdorph, R., Powell, R. L., Armstrong, M., Piganelli, J. D., Barbour, G., Bradley, B., Crawford, F., et al. (2010) · Nature Immunology · doi:10.1038/ni.1844 · Cited by 338
Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway
Fife, B. T., Guleria, I., Gubbels Bupp, M., Eagar, T. N., Tang, Q., Bour-Jordan, H., Yagita, H., Azuma, M., Sayegh, M. H., & Bluestone, J. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061577 · Cited by 325
Self-citationThe Pathogenesis and Natural History of Type 1 Diabetes
Atkinson, M. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007641 · Cited by 314
Serreze, D. V., Leiter, E. H., Christianson, G. J., Greiner, D., & Roopenian, D. C. (1994) · Diabetes · doi:10.2337/diab.43.3.505 · Cited by 301
Babon, J. A. B., DeNicola, M. E., Blodgett, D. M., Crèvecoeur, I., Buttrick, T. S., Maehr, R., Bottino, R., Naji, A., Kaddis, J., Elyaman, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4203 · Cited by 300
B-Cells Are Required for the Initiation of Insulitis and Sialitis in Nonobese Diabetic Mice
Noorchashm, H., Noorchashm, N., Kern, J., Rostami, S. Y., Barker, C. F., & Naji, A. (1997) · Diabetes · doi:10.2337/diab.46.6.941 · Cited by 266
Insulin Expression Levels in the Thymus Modulate Insulin-Specific Autoreactive T-Cell Tolerance
Chentoufi, A. A., & Polychronakos, C. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1383 · Cited by 264
Sun, J. K., Keenan, H. A., Cavallerano, J. D., Asztalos, B. F., Schaefer, E. J., Sell, D. R., Strauch, C. M., Monnier, V. M., Doria, A., Aiello, L. P., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1675 · Cited by 261
Zheng, X. X., Sánchez-Fueyo, A., Sho, M., Domenig, C., Sayegh, M. H., & Strom, T. B. (2003) · Immunity · doi:10.1016/s1074-7613(03)00259-0 · Cited by 248
Pancreatic islet-specific T-cell clones from nonobese diabetic mice.
Haskins, K., Portas, M., Bergman, B., Lafferty, K., & Bradley, B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.8000 · Cited by 242
Rodriguez-Calvo, T., Ekwall, O., Amirian, N., Zapardiel-Gonzalo, J., & von Herrath, M. G. (2014) · Diabetes · doi:10.2337/db14-0549 · Cited by 241
T cell suppression in transplantation tolerance through linked recognition
Davies, J. D., Leong, L. Y., Mellor, A., Cobbold, S. P., & Waldmann, H. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3602 · Cited by 239
Recurrence of Disease in Pancreas Transplants
Sutherland, D. E., Goetz, F. C., & Sibley, R. K. (1989) · Diabetes · doi:10.2337/diab.38.1.s85 · Cited by 234
Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes
Kracht, M. J. L., van Lummel, M., Nikolic, T., Joosten, A. M., Laban, S., van der Slik, A. R., van Veelen, P. A., Carlotti, F., de Koning, E. J. P., Hoeben, R. C., et al. (2017) · Nature Medicine · doi:10.1038/nm.4289 · Cited by 234
Suk, K., Kim, S., Kim, Y.-H., Kim, K.-A., Chang, I., Yagita, H., Shong, M., & Lee, M.-S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4481 · Cited by 223
Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP
Krishnamurthy, B., Dudek, N. L., McKenzie, M. D., Purcell, A. W., Brooks, A. G., Gellert, S., Colman, P. G., Harrison, L. C., Lew, A. M., Thomas, H. E., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29602 · Cited by 223
Srikanta, S., Ganda, O. P., Rabizadeh, A., Soeldner, J. S., & Eisenbarth, G. S. (1985) · New England Journal of Medicine · doi:10.1056/nejm198508223130801 · Cited by 222
HOW DO MONOCLONAL ANTIBODIES INDUCE TOLERANCE? A Role for Infectious Tolerance?
Waldmann, H., & Cobbold, S. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.619 · Cited by 215
Arif, S., Moore, F., Marks, K., Bouckenooghe, T., Dayan, C. M., Planas, R., Vives-Pi, M., Powrie, J., Tree, T., Marchetti, P., et al. (2011) · Diabetes · doi:10.2337/db10-1643 · Cited by 213
Detection of β cell death in diabetes using differentially methylated circulating DNA
Akirav, E. M., Lebastchi, J., Galvan, E. M., Henegariu, O., Akirav, M., Ablamunits, V., Lizardi, P. M., & Herold, K. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111008108 · Cited by 211
Converting Adult Pancreatic Islet α Cells into β Cells by Targeting Both Dnmt1 and Arx
Chakravarthy, H., Gu, X., Enge, M., Dai, X., Wang, Y., Damond, N., Downie, C., Liu, K., Wang, J., Xing, Y., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.01.009 · Cited by 211
Antigen Targets of Type 1 Diabetes Autoimmunity
Roep, B. O., & Peakman, M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007781 · Cited by 210
Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients
Gaglia, J. L., Guimaraes, A. R., Harisinghani, M., Turvey, S. E., Jackson, R., Benoist, C., Mathis, D., & Weissleder, R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44339 · Cited by 209
Autoimmune islet destruction in spontaneous type 1 diabetes is not β-cell exclusive
Winer, S., Tsui, H., Lau, A., Song, A., Li, X., Cheung, R. K., Sampson, A., Afifiyan, F., Elford, A., Jackowski, G., et al. (2003) · Nature Medicine · doi:10.1038/nm818 · Cited by 200
Insulin as an autoantigen in NOD/human diabetes
Zhang, L., Nakayama, M., & Eisenbarth, G. S. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.11.005 · Cited by 197
Ricordi, C., Goldstein, J. S., Balamurugan, A. N., Szot, G. L., Kin, T., Liu, C., Czarniecki, C. W., Barbaro, B., Bridges, N. D., Cano, J., et al. (2016) · Diabetes · doi:10.2337/db16-0234 · Cited by 196
T-Lymphocyte Clone Specific for Pancreatic Islet Antigen
Haskins, K., Portas, M., Bradley, B., Wegmann, D., & Lafferty, K. (1988) · Diabetes · doi:10.2337/diab.37.10.1444 · Cited by 194
Diabetic kidney disease: from physiology to therapeutics
Mora‐Fernández, C., Domínguez‐Pimentel, V., de Fuentes, M. M., Górriz, J. L., Martínez‐Castelao, A., & Navarro‐González, J. F. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.272328 · Cited by 194
NK cells promote islet allograft tolerance via a perforin-dependent mechanism
Beilke, J. N., Kuhl, N. R., Kaer, L. V., & Gill, R. G. (2005) · Nature Medicine · doi:10.1038/nm1296 · Cited by 191
Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes
Michels, A. W., Landry, L. G., McDaniel, K. A., Yu, L., Campbell-Thompson, M., Kwok, W. W., Jones, K. L., Gottlieb, P. A., Kappler, J. W., Tang, Q., et al. (2017) · Diabetes · doi:10.2337/db16-1025 · Cited by 190
DiLorenzo, T. P., Graser, R. T., Ono, T., Christianson, G. J., Chapman, H. D., Roopenian, D. C., Nathenson, S. G., & Serreze, D. V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12538 · Cited by 181
Wicker, L. S., Appel, M. C., Dotta, F., Pressey, A., Miller, B. J., DeLarato, N. H., Fischer, P. A., Boltz, R. C., & Peterson, L. B. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.67 · Cited by 179
Defective Central Tolerance Induction in NOD Mice: Genomics and Genetics
Zucchelli, S., Holler, P., Yamagata, T., Roy, M., Benoist, C., & Mathis, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.015 · Cited by 178
Roep, B. O., Solvason, N., Gottlieb, P. A., Abreu, J. R. F., Harrison, L. C., Eisenbarth, G. S., Yu, L., Leviten, M., Hagopian, W. A., Buse, J. B., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006103 · Cited by 170
Effector Mechanisms in Low‐Dose Streptozotocin‐induced Diabetes
Lukić, M. L., Stošić-Grujičić, S., & Shahin, A. (1998) · Journal of Immunology Research · doi:10.1155/1998/92198 · Cited by 168
Pathiraja, V., Kuehlich, J. P., Campbell, P. D., Krishnamurthy, B., Loudovaris, T., Coates, P. T. H., Brodnicki, T. C., O’Connell, P. J., Kedzierska, K., Rodda, C., et al. (2015) · Diabetes · doi:10.2337/db14-0858 · Cited by 165
Ferris, S. T., Carrero, J. A., Mohan, J. F., Calderon, B., Murphy, K. M., & Unanue, E. R. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.012 · Cited by 164
Expression and Regulation of Chemokines in Murine and Human Type 1 Diabetes
Sarkar, S. A., Lee, C. E., Victorino, F., Nguyen, T. T., Walters, J. A., Burrack, A., Eberlein, J., Hildemann, S. K., & Homann, D. (2011) · Diabetes · doi:10.2337/db11-0853 · Cited by 150
Self-citationThe role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice.
Wang, Y., Pontesilli, O., Gill, R. G., Rosa, F. G. L., & Lafferty, K. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.2.527 · Cited by 148
Han, B., Serra, P., Amrani, A., Yamanouchi, J., Marée, A. F. M., Edelstein‐Keshet, L., & Santamaría, P. (2005) · Nature Medicine · doi:10.1038/nm1250 · Cited by 142
Yang, J., Chow, I., Sosinowski, T., Torres-Chinn, N., Greenbaum, C. J., James, E. A., Kappler, J. W., Davidson, H. W., & Kwok, W. W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416864111 · Cited by 131
Calderón, B., Suri, A., & Unanue, E. R. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060539 · Cited by 128
Mouse models for Type 1 Diabetes
Belle, T. L. V., Taylor, P., & von Herrath, M. G. (2009) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2009.03.008 · Cited by 128
Atkinson, M. A., Kaufman, D. L., Newman, D., Tobin, A. J., & Maclaren, N. K. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116192 · Cited by 123
Prasad, S., Kohm, A. P., McMahon, J. S., Luo, X., & Miller, S. D. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.04.005 · Cited by 121
Molecular control of regulatory T cell development and function
Kitagawa, Y., & Sakaguchi, S. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.10.002 · Cited by 121
Autoimmune Diabetes in NOD Mouse Is L3T4 T-Lymphocyte Dependent
Wang, Y., Hao, L., Gill, R. G., & Lafferty, K. J. (1987) · Diabetes · doi:10.2337/diab.36.4.535 · Cited by 119
Beta cell MHC class I is a late requirement for diabetes
Hamilton‐Williams, E. E., Palmer, S. E., Charlton, B., & Slattery, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131954100 · Cited by 116
Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes
McLaughlin, K. A., Richardson, C. C., Ravishankar, A., Brigatti, C., Liberati, D., Lampasona, V., Piemonti, L., Morgan, D., Feltbower, R. G., & Christie, M. R. (2016) · Diabetes · doi:10.2337/db15-1058 · Cited by 113 · cited 1×
“Interestingly, some T1D but not T2D subjects develop autoantibodies against the neuroendocrine protein tetraspanin7 from sympthatheic nerves within islets (142).”
BackgroundNOD mice have a generalized defect in their response to transplantation tolerance induction.
Markees, T. G., SERREZE, D. V., Phillips, N. E., SORLI, C. H., Gordon, E. J., Shultz, L. D., Noelle, R. J., Woda, B. A., Greiner, D. L., Mordes, J. P., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.5.967 · Cited by 113
Chen, W., Bergerot, I., Elliott, J. F., Harrison, L. C., Abiru, N., Eisenbarth, G. S., & Delovitch, T. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.4926 · Cited by 112
Martinez, R. J., Zhang, N., Thomas, S. R., Nandiwada, S. L., Jenkins, M. K., Binstadt, B. A., & Mueller, D. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101311 · Cited by 111
Loss of NADPH Oxidase–Derived Superoxide Skews Macrophage Phenotypes to Delay Type 1 Diabetes
Padgett, L. E., Burg, A. R., Lei, W., & Tse, H. M. (2014) · Diabetes · doi:10.2337/db14-0929 · Cited by 111
Yang, J., Danke, N. A., Berger, D., Reichstetter, S., Reijonen, H., Greenbaum, C. J., Pihoker, C., James, E. A., & Kwok, W. W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.2781 · Cited by 109
Pathogenesis of Painful Diabetic Neuropathy
Aslam, A., Singh, J., & Rajbhandari, S. M. (2014) · Pain Research and Treatment · doi:10.1155/2014/412041 · Cited by 108
Tse, H. M., Milton, M. J., Schreiner, S., Profozich, J., Trucco, M., & Piganelli, J. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.908 · Cited by 108
Pietropaolo, M., Towns, R., & Eisenbarth, G. S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012831 · Cited by 105
Hutchings, P. R., Reilly, L. O., Parish, N. M., Waldmann, H., & Cooke, A. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220735 · Cited by 104
Spontaneous Diabetes in Rats: Destruction of Islets Is Prevented by Immunological Tolerance
Naji, A., Silvers, W. K., Bellgrau, D., & Barker, C. F. (1981) · Science · doi:10.1126/science.6791286 · Cited by 103
Thayer, T. C., Delano, M. J., Liu, C., Chen, J., Padgett, L. E., Tse, H. M., Annamali, M., Piganelli, J. D., Moldawer, L. L., & Mathews, C. E. (2011) · Diabetes · doi:10.2337/db10-1222 · Cited by 103
Nanji, S. A., Hancock, W. W., Luo, B., Schur, C. D., Pawlick, R. L., Zhu, L. F., Anderson, C. C., & Shapiro, A. M. J. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db04-1154 · Cited by 103
Recognition of HLA Class I–Restricted β-Cell Epitopes in Type 1 Diabetes
Ouyang, Q., Standifer, N. E., Qin, H., Gottlieb, P. A., Verchere, C. B., Nepom, G. T., Tan, R., & Panagiotopoulos, C. (2006) · Diabetes · doi:10.2337/db06-0065 · Cited by 102
Wiles, T. A., Delong, T., Baker, R. L., Bradley, B., Barbour, G., Powell, R. L., Reisdorph, N. A., & HASKINS, K. M. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.10.007 · Cited by 98
Nikolić, T., Geutskens, S. B., van Rooijen, N., Drexhage, H. A., & Leenen, P. J. M. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700238 · Cited by 96
Molano, R. D., Berney, T., Li, H., Cattan, P., Pileggi, A., Vizzardelli, C., Kenyon, N. S., Ricordi, C., Burkly, L. C., & Inverardi, L. (2001) · Diabetes · doi:10.2337/diabetes.50.2.270 · Cited by 96
Thinking bedside at the bench: the NOD mouse model of T1DM
Reed, J. C., & Herold, K. C. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.236 · Cited by 95
Sarikonda, G., Pettus, J., Phatak, S., Sachithanantham, S., Miller, J. F., Wesley, J. D., Cadag, E., Chae, J., Ganesan, L., Mallios, R., et al. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.12.003 · Cited by 93
Antigen-specific induced Foxp3 + regulatory T cells are generated following CD40/CD154 blockade
Ferrer, I. R., Wagener, M. E., Song, M., Kirk, A. D., Larsen, C. P., & Ford, M. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105500108 · Cited by 93
Nicolls, M. R., Coulombe, M., Beilke, J. N., Gelhaus, H. C., & Gill, R. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4831 · Cited by 90
Mundinger, T. O., Mei, Q., Foulis, A. K., Fligner, C. L., Hull, R. L., & Taborsky, G. J. (2016) · Diabetes · doi:10.2337/db16-0284 · Cited by 86
Öling, V., Marttila, J., Ilonen, J., Kwok, W. W., Nepom, G. T., Knip, M., Simell, O., & Reijonen, H. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.09.018 · Cited by 85
Pathogenic T‐Cell Clones in Autoimmune Diabetes: More Lessons from the NOD Mouse
HASKINS, K. M. (2005) · Advances in immunology · doi:10.1016/s0065-2776(05)87004-x · Cited by 84
Human Type 1 Diabetes Is Associated with T Cell Autoimmunity to Zinc Transporter 8
Dang, M., Rockell, J., Wagner, R., Wenzlau, J. M., Yu, L., Hutton, J. C., Gottlieb, P. A., & Davidson, H. W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003815 · Cited by 84
Yolcu, E. S., Zhao, H., Bandura-Morgan, L., Lacelle, C., Woodward, K. B., Askenasy, N., & Shirwan, H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003266 · Cited by 82
Recurrence of Autoimmunity Following Pancreas Transplantation
Burke, G. W., Vendrame, F., Pileggi, A., Ciancio, G., Reijonen, H., & Pugliese, A. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0206-y · Cited by 81
Heterogeneity and Lobularity of Pancreatic Pathology in Type 1 Diabetes during the Prediabetic Phase
Calvo, T. R., Suwandi, J. S., Amirian, N., Zapardiel‐Gonzalo, J., Anquetil, F., Sabouri, S., & von Herrath, M. G. (2015) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155415576543 · Cited by 80
Chromogranin A is a T cell antigen in human type 1 diabetes
Gottlieb, P. A., Delong, T., Baker, R. L., Fitzgerald-Miller, L., Wagner, R., Cook, G., Rewers, M., Michels, A. W., & HASKINS, K. M. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.10.003 · Cited by 80
Development of Insulitis and Diabetes in B Cell-Deficient NOD Mice
Yang, M., Charlton, B., & Gautam, A. M. (1997) · Journal of Autoimmunity · doi:10.1006/jaut.1997.0128 · Cited by 80
Mullen, Y. (2017) · Pancreas · doi:10.1097/mpa.0000000000000828 · Cited by 78
Wenzlau, J. M., Walter, M., Gardner, T. J., Frisch, L. M., Yu, L., Eisenbarth, G. S., Ziegler, A., Davidson, H. W., & Hutton, J. C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0169 · Cited by 76
Seay, H. R., Putnam, A. L., Cserny, J., Posgai, A. L., Rosenau, E. H., Wingard, J. R., Girard, K. F., Kraus, M., Lares, A., Brown, H. L. G., et al. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2016.12.003 · Cited by 75
Mora, C., Wong, F. S., Chang, C., & Flavell, R. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4576 · Cited by 72
Antkowiak, P. F., Tersey, S. A., Carter, J. D., Vandsburger, M. H., Nadler, J. L., Epstein, F. H., & Mirmira, R. G. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90336.2008 · Cited by 71
Direct and indirect allograft recognition: pathways dictating graft rejection mechanisms
Lin, C. M., & Gill, R. (2016) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000263 · Cited by 71
The Role of Autoimmunity in Islet Allograft Destruction
Makhlouf, L., Kishimoto, K., Smith, R. N., Abdi, R., Koulmanda, M., Winn, H. J., Auchincloss, H., & Sayegh, M. H. (2002) · Diabetes · doi:10.2337/diabetes.51.11.3202 · Cited by 67
Gerling, I., Friedman, H. P., Greiner, D. L., et al. (1994) · Diabetes · doi:10.2337/diab.43.3.433 · Cited by 66
Lamhamedi-Cherradi, S.-E., Luan, J.-J., Eloy, L., Fluteau, G., Bach, J., & Garchon, H. (1998) · Diabetologia · doi:10.1007/s001250050887 · Cited by 65
Endogenous Memory CD8 T Cells Directly Mediate Cardiac Allograft Rejection
Su, C. A., Iida, S., Abe, T., & Fairchild, R. L. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12605 · Cited by 64
Bellemore, S. M., Nikoopour, E., Schwartz, J. A., Krougly, O., Lee‐Chan, E., & Singh, B. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12691 · Cited by 63
Lessons From Pancreas Transplantation in Type 1 Diabetes: Recurrence of Islet Autoimmunity
Burke, G. W., Vendrame, F., Virdi, S. K., Ciancio, G., Chen, L., Ruiz, P., Messinger, S., Reijonen, H., & Pugliese, A. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0691-5 · Cited by 62
ZnT8 Is a Major CD8+ T Cell–Recognized Autoantigen in Pediatric Type 1 Diabetes
Waeckel-Énée, E., Kratzer, R., Arnoux, J., Barilleau, É., Hamel, Y., Marchi, C., Beltrand, J., Michaud, B., Chatenoud, L., Robert, J., et al. (2012) · Diabetes · doi:10.2337/db12-0071 · Cited by 62
Pöllänen, P. M., Lempainen, J., Laine, A., Toppari, J., Veijola, R., Vähäsalo, P., Ilonen, J., Siljander, H., & Knip, M. (2017) · Diabetologia · doi:10.1007/s00125-017-4258-7 · Cited by 62
Soeldner, J. S., Tuttleman, M., Srikanta, S., Ganda, O. P., & Eisenbarth, G. S. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510033131417 · Cited by 61
Kawasaki, E., Eisenbarth, G. S., Wasmeier, C., & Hutton, J. C. (1996) · Diabetes · doi:10.2337/diab.45.10.1344 · Cited by 60
Islet Amyloid Polypeptide Is a Target Antigen for Diabetogenic CD4+ T Cells
Delong, T., Baker, R., Reisdorph, N., Reisdorph, R., Powell, R., Armstrong, M., Barbour, G., Bradley, B., & Haskins, K. (2011) · Diabetes · doi:10.2337/db11-0288 · Cited by 60
IFN-γ-Dependent Regulatory Circuits in Immune Inflammation Highlighted in Diabetes
Calderón, B., Suri, A., Pan, X., Mills, J. C., & Unanue, E. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.6964 · Cited by 60
Islet Allografts Are Destroyed by Disease Occurrence in the Spontaneously Diabetic BB Rat
Prowse, S. J., Bellgrau, D., & Lafferty, K. J. (1986) · Diabetes · doi:10.2337/diab.35.1.110 · Cited by 59
Preferential Priming of Alloreactive T cells with Indirect Reactivity
Brennan, T., Jaigirdar, A., Hoang, V., Hayden, T., Liu, F.-C., Zaid, H., Chang, C. K., Bucy, R. P., Tang, Q., & Kang, S.-M. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02578.x · Cited by 57
Khatib, M. M. E., Sakuma, T., Tonne, J. M., Mohamed, M. S., Holditch, S. J., Lu, B., Kudva, Y. C., & Ikeda, Y. (2015) · Gene Therapy · doi:10.1038/gt.2015.18 · Cited by 57
Jin, N., Wang, Y., Crawford, F., White, J., Marrack, P., Dai, S., & Kappler, J. W. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517862112 · Cited by 57
Yang, J., Danke, N. A., Roti, M., Huston, L., Greenbaum, C. J., Pihoker, C., James, E. A., & Kwok, W. W. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.02.001 · Cited by 56
Circulating Differentially Methylated Amylin DNA as a Biomarker of β-Cell Loss in Type 1 Diabetes
Olsen, J. A., Kenna, L. A., Spelios, M. G., Hessner, M. J., & Akirav, E. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152662 · Cited by 55
Ott, P. A., Dittrich, M. T., Herzog, B. A., Guerkov, R., Gottlieb, P. A., Putnam, A. L., Durinovic‐Belló, I., Boehm, B. O., Tary‐Lehmann, M., & Lehmann, P. (2004) · Journal of Clinical Immunology · doi:10.1023/b:joci.0000029120.77824.41 · Cited by 54
Melanitou, E., Devendra, D., Liu, E., Miao, D., & Eisenbarth, G. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6603 · Cited by 52
Mouse pancreatic beta cells express MHC class II and stimulate CD4 + T cells to proliferate
Zhao, Y., Scott, N. A., Quah, H. S., Krishnamurthy, B., Bond, F., Loudovaris, T., Mannering, S. I., Kay, T. W. H., & Thomas, H. E. (2015) · European Journal of Immunology · doi:10.1002/eji.201445378 · Cited by 52
Kawasaki, E., Hutton, J. C., & Eisenbarth, G. S. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1526 · Cited by 52
Zhao, Z., Miao, D., Michels, A. W., Steck, A. K., Dong, F., Rewers, M., & Yu, L. (2016) · Journal of Immunological Methods · doi:10.1016/j.jim.2016.01.011 · Cited by 52
Do MHCII-Presented Neoantigens Drive Type 1 Diabetes and Other Autoimmune Diseases?Preprint
Marrack, P., & Kappler, J. W. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007765 · Cited by 49
Makhlouf, L., Yamada, A., Ito, T., Abdi, R., Ansari, M., Khuong, C., Winn, H., Auchincloss, H., & Sayegh, M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000079041.15707.a9 · Cited by 49
Memory CD4 T Cells Induce Antibody-Mediated Rejection of Renal Allografts
Gorbacheva, V., Fan, R., Fairchild, R. L., Baldwin, W. M., & Valujskikh, A. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015080848 · Cited by 49
Berney, T., Pileggi, A., Molano, R. D., Poggioli, R., Zahr, E., Ricordi, C., & Inverardi, L. (2003) · Transplantation · doi:10.1097/01.tp.0000092525.17025.d0 · Cited by 48
Pauken, K. E., Linehan, J. L., Spanier, J. A., Sahli, N. L., Kalekar, L. A., Binstadt, B. A., Moon, J. J., Mueller, D. L., Jenkins, M. K., & Fife, B. T. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301927 · Cited by 48
Self-citationIA-2 is not required for the development of diabetes in NOD mice
Kubosaki, A., Miura, J., & Notkins, A. L. (2004) · Diabetologia · doi:10.1007/s00125-003-1252-z · Cited by 47
β-Cell–Specific IL-2 Therapy Increases Islet Foxp3+Treg and Suppresses Type 1 Diabetes in NOD Mice
Johnson, M. C., Garland, A. L., Nicolson, S. C., Li, C., Samulski, R. J., Wang, B., & Tisch, R. (2013) · Diabetes · doi:10.2337/db13-0669 · Cited by 47
Spanier, J. A., Sahli, N. L., Wilson, J. C., Martinov, T., Dileepan, T., Burrack, A. L., Finger, E. B., Blazar, B. R., Michels, A. W., Moran, A., et al. (2017) · Diabetes · doi:10.2337/db17-0666 · Cited by 47
Self-citationLangsford, D., & Dwyer, K. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i10.1132 · Cited by 44
Baker, R. L., Delong, T., Barbour, G., Bradley, B., Nakayama, M., & HASKINS, K. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301480 · Cited by 40
MHC-Mismatched Islet Allografts Are Vulnerable to Autoimmune Recognition In Vivo
Kupfer, T., Crawford, M. L., Pham, K., & Gill, R. G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2309 · Cited by 37
Prasad, S., Xu, D., & Miller, S. D. (2012) · The Review of Diabetic Studies · doi:10.1900/rds.2012.9.319 · Cited by 36
Tolerance to antigen-presenting cell-depleted islet allografts is CD4 T cell dependent.
Coulombe, M., Yang, H., Wolf, L. A., & Gill, R. G. (1999) · Journal of Immunology · doi:10.4049/jimmunol.162.5.2503 · Cited by 36
Rajaei, B., Shamsara, M., Amirabad, L. M., Massumi, M., & Sanati, M. H. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25459 · Cited by 35
Bender, C., Christen, S., Scholich, K., Bayer, M., Pfeilschifter, J. M., Hintermann, E., & Christen, U. (2016) · Diabetes · doi:10.2337/db16-0547 · Cited by 35
Mahne, A. E., Klementowicz, J. E., Chou, A. Y., Nguyen, V. Q., & Tang, Q. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402739 · Cited by 33
Demeester, S., Keymeulen, B., Kaufman, L., Dalem, A. V., Balti, E. V., de Velde, U. V., Goubert, P., Verhaeghen, K., Davidson, H. W., Wenzlau, J. M., et al. (2015) · Diabetes Care · doi:10.2337/dc14-1575 · Cited by 32
Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes
Itoh, A., & Ridgway, W. M. (2017) · ImmunoTargets and Therapy · doi:10.2147/itt.s117264 · Cited by 32
Winer, S., Astsaturov, I. A., Gaedigk, R., Hammond-McKibben, D., Pilon, M., Song, A., Kubiak, V., Karges, W., Arpaia, E., McKerlie, C., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.475 · Cited by 31
HLA-DQ8-Associated T Cell Responses to the Diabetes Autoantigen Phogrin (IA-2β) in Human Prediabetes
Kelemen, K., Gottlieb, P. A., Putnam, A. L., Davidson, H. W., Wegmann, D. R., & Hutton, J. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3955 · Cited by 30
Current issues in allogeneic islet transplantation
Chang, C. A., Lawrence, M. C., & Naziruddin, B. (2017) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000448 · Cited by 30
Assalino, M., Genevay, M., Morel, P., Demuylder-Mischler, S., Toso, C., & Berney, T. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03844.x · Cited by 29
Padgett, L. E., Anderson, B. M., Liu, C., Ganini, D., Mason, R. P., Piganelli, J. D., Mathews, C. E., & Tse, H. M. (2015) · Diabetes · doi:10.2337/db15-0546 · Cited by 28
Immunology of pancreatic islet transplantation
Reffet, S., & Thivolet, C. H. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(06)72805-1 · Cited by 27
Schloot, N. C., Daniel, D., Norbury-Glaser, M., & Wegmann, D. R. (1996) · Journal of Autoimmunity · doi:10.1006/jaut.1996.0048 · Cited by 27
An islet-homing NOD CD8+cytotoxic T cell clone recognizes GAD65and causes insulitis
Videbæk, N., Harach, S. Z., Phillips, J. M., Hutchings, P. R., Ozegbe, P., Michelsen, B. K., & Cooke, A. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00003-9 · Cited by 27
Drage, M. W., Zaccone, P., Phillips, J. M., et al. (2002) · Transplantation · doi:10.1097/00007890-200209150-00005 · Cited by 27
von Herrath, M. G., Homann, D., Gairin, J. E., & Oldstone, M. B. A. (1997) · Biochemical Society Transactions · doi:10.1042/bst0250630 · Cited by 27
Nayak, D. K., Calderón, B., Vomund, A. N., & Unanue, E. R. (2014) · Diabetes · doi:10.2337/db13-1882 · Cited by 25
Biologic Agents in Islet Transplantation
Gala-Lopez, B., Pepper, A., & Shapiro, A. M. J. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0414-8 · Cited by 25
Trends in immunosuppression after pancreas transplantation: what is in the pipeline?
Kimelman, M., & Brandacher, G. (2012) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32835c6eda · Cited by 24
Mapping of conformational autoantibody epitopes in ZNT8
Wenzlau, J. M., Frisch, L. M., Hutton, J. C., & Davidson, H. W. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1266 · Cited by 22
Kelemen, K., Crawford, M. L., Gill, R. G., Hutton, J. C., & Wegmann, D. R. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1529 · Cited by 22
Xu, X., Gu, Y., Bian, L., Shi, Y., Cai, Y., Chen, Y., Chen, H., Li, Q., Wu, X., Xu, K., et al. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.108 · Cited by 21
Is diabetic cardiomyopathy a specific entity?
Letonja, M., & Petrovič, D. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i1.8 · Cited by 21
Stem Cell Therapies in the Management of Diabetic Retinopathy
Megaw, R. D., & Dhillon, B. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0498-9 · Cited by 19
Multiple antigens versus single major antigen in type 1 diabetes: arguing for multiple antigens
DiLorenzo, T. P. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1251 · Cited by 19
Bose, B., & Sudheer, P. S. (2015) · Methods in molecular biology · doi:10.1007/7651_2015_230 · Cited by 17
Regnault, B., y Fortéa, J. O., Miao, D., Eisenbarth, G. S., & Melanitou, E. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-63 · Cited by 17
Viret, C., Mahiddine, K., Baker, R. L., HASKINS, K. M., & Guerder, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401683 · Cited by 16
Gomez-Touriño, I. M., Simón‐Vázquez, R., Alonso, J., Arif, S., Calviño, C., González‐Fernández, Á., González, E. P., Rodríguez, J. R., Viñuela, J. E., Verdaguer, J., et al. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12572 · Cited by 13
Glucagon‐reactive islet‐infiltrating CD 8 T cells in NOD mice
Mukherjee, G., Chaparro, R. J., Schloss, J. M., Smith, C., Bando, C. D., & DiLorenzo, T. P. (2014) · Immunology · doi:10.1111/imm.12415 · Cited by 11
Cited by
The impact of the gut microbiome on extra-intestinal autoimmune diseases
Miyauchi, E., Shimokawa, C., Steimle, A., Desai, M. S., & Ohno, H. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00727-y · Cited by 367
Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress
Wu, X., Jiang, J., Gu, Z., Zhang, J., Chen, Y., & Liu, X. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01855-9 · Cited by 343
“Type 1 diabetes is a form of diabetes mellitus that results from T cell-mediated autoimmune destruction of insulin-producing pancreatic β cells as well as decreasing insulin secretion owing to anti-islet autoantibodies [217, 218].”
BackgroundCurrent understandings of the pathogenesis of type 1 diabetes: genetics to environment
Giwa, A. M., Ahmed, R., Omidian, Z., Majety, N., Karakus, K. E., Omer, S. M., Donner, T., & Hamad, A. R. A. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i1.13 · Cited by 137
Probiotics and prebiotics for the amelioration of type 1 diabetes: Present and future perspectives
Mishra, S., Wang, S., Nagpal, R., Miller, B., Singh, R., Taraphder, S., & Yadav, H. (2019) · Microorganisms · doi:10.3390/microorganisms7030067 · Cited by 131
Abdelsamed, H. A., Zebley, C. C., Nguyen, H., Rutishauser, R. L., Fan, Y., Ghoneim, H. E., Crawford, J. C., Alfei, F., Alli, S., Ribeiro, S. P., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0633-5 · Cited by 121
Metadata
- Authors
- Burrack, A. L., Martinov, T., & Fife, B. T.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2017-12-05
- Volume
- 8
- Pages
- 343-343
- ISSN
- 1664-2392 (ISSN-L)
- OpenAlex
- W2773213563
- Cited by
- 330
- References
- 181
- FWCI
- 9.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.